1-4 of 4
Catherine D Falkenstein
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Alternative splicing of its 5′-UTR limits CD20 mRNA translation and enables resistance to CD20-directed immunotherapies

Zhiwei Ang, Luca Paruzzo, Katharina E. Hayer, Carolin Schmidt, Manuel Torres Diz, Feng Xu, Urvi Zankharia, Yunlin Zhang, Samantha Soldan, Sisi Zheng, Catherine D. Falkenstein, Joseph P. Loftus, Scarlett Y. Yang, Mukta Asnani, Patricia King Sainos, Vinodh Pillai, Emeline Chong, Marilyn M. Li, Sarah K. Tasian, Yoseph Barash, Paul M. Lieberman, Marco Ruella, Stephen J. Schuster, Andrei Thomas-Tikhonenko
Journal: Blood
Blood (2023) 142 (20): 1724–1739.
https://doi.org/10.1182/blood.2023020400
Published: 2023
Includes: Supplemental data
Journal Articles

Non-Canonical Exon Usage in Pediatric Leukemia: Implications for Chemoresistance

Manuel Torres-Diz, Andrei Thomas-Tikhonenko, Clara Reglero, Adolfo Ferrando, Catherine D Falkenstein, Sarah K Tasian, Priyanka Sehgal, Zhiwei Ang, Yoseph Barash, Caleb Radens
Journal: Blood
Blood (2022) 140 (Supplement 1): 3264–3265.
https://doi.org/10.1182/blood-2022-167006
Published: 2022
Journal Articles

Transcriptional Rewiring and Therapeutic Resistance in Philadelphia Chromosome-like Acute Lymphoblastic Leukemia

Yang Y Ding, Joseph Patrick Loftus, Benjamin Mathier, Wenbao Yu, David Hottman Allen, Bing He, Catherine D Falkenstein, Sarah K Tasian, Kai Tan
Journal: Blood
Blood (2022) 140 (Supplement 1): 354–355.
https://doi.org/10.1182/blood-2022-169341
Published: 2022
Journal Articles

Preclinical In Vivo Activity of the Menin Inhibitor Ziftomenib (KO-539) in Pediatric KMT2A -Rearranged Acute Lymphoblastic Leukemia

Catherine D Falkenstein, Lisa M Niswander, Linda Kessler, Blake Tomkinson, Francis Burrows, Sarah K Tasian
Journal: Blood
Blood (2022) 140 (Supplement 1): 3491–3492.
https://doi.org/10.1182/blood-2022-157225
Published: 2022